HTN 100

HTN 100: TPP working with Servelec, Concepta hires CEO, Creavo begins new study and user adoption platform launched

TPP and Servelec to drive closer integration 

TPP has announced it will be working with Servelec to deliver integration between Rio and the SystmOne GP platform.

SystmOne and Rio user East London NHS Foundation Trust and BLMK ICS are supporting this initiative over the next few weeks.

Simon Fewer, Interim Chief Information Officer, East London Foundation Trust “ELFT’s vision to improve the health of our community by 2022 is supported by a Digital strategy and plan to achieve interoperability and shared care records across our local healthcare partners. This development will enable shared records to support high quality direct patient care across our mental health and community services with GP practices in Bedfordshire and Luton.”

As part of the collaboration, data will be shared across both platforms to provide a view of data from both systems on a single screen, providing a complete picture of a patient’s health record.


Penelope McCormick joins Concepta Diagnostics as Chief Executive Officer

Penny will be joining Concepta from medical diagnostic firm BBI Group where she worked for 12 years, leading as Managing Director of BBI Healthcare Ltd. 

Commenting on the appointment, Chairman Adam Reynolds, said “Penny brings a wealth of commercial leadership experience in the medical devices and women’s healthcare sectors. She has an outstanding track record that is highly synergistic with the Concepta business model and market proposition, and that experience will be invaluable in steering the company through the operational and management developments required to achieve its next phase of growth.”

Penny stated, “I am proud to be part of a forward-thinking organisation that is working to accelerate innovation in the femtech and women’s healthcare sphere. The company has exceptional market-leading technology that can make a significant difference to the lives of women who are looking to conceive, and I look forward to leading the business through the next exciting phase.”


Creavo begins ground breaking study into sudden cardiac death at University Hospitals Coventry and Warwickshire

Medical device company Creavo Medical Technologies has begun a 510-patient study with University Hospitals Coventry and Warwickshire NHS Trust, to evaluate the role of magnetocardiography (MCG) in the prediction of ventricular arrhythmias in patients who have been identified at risk of sudden cardiac death.

The study will involve performing MCG scans – which generate a magnetic field map of the heart – on patients who fulfil National Institute for Health and Care Excellence guidelines for receiving an implantable cardioverter-defibrillator (ICD).

Dr Lachlan said: “Currently, the majority of ICDs are implanted in patients who have suffered a myocardial infarction and are known to have a weakened heart, but research suggests only around 10-15% of ICD recipients subsequently suffer a ventricular arrythmia and receive a treatment from their ICD.”

“This means that a significant number of patients deemed ‘at risk’ are implanted with ICDs which are never needed, and this can be severely detrimental to their overall health as well as being a costly undertaking for health services.”

“We are excited by the potential of this study to more accurately predict which patients will develop a ventricular arrhythmia that requires therapy from the ICD, and therefore improve health outcomes for those at risk of SCD and enable health services to more efficiently allocate their resources.”

Steve Parker, Chief Executive Officer at Creavo said “We’re very proud of the fact that this study is the first ever to attempt to correlate patterns in the heart’s magnetic field with future ventricular arrhythmias.”

“The study, which uses Creavo’s technology, will help assess the potential for MCG to be used as a vital screening tool outside of emergency care. This is an important step in our journey, and we thank the team at University Hospitals Coventry and Warwickshire for their involvement and support.”


Health tech user adoption learning platform launches 

ANCILE Solutions has moved into UK healthcare with its uPerform platform that is used by 4,600 organisations globally.

The platform provides a fast and effective way to train and support staff on electronic patient record and other clinical systems; and to make sure that new and locum staff can use installed technology safely and effectively.

Johnathan Pascall, EMEA sales director for ANCILE Solutions, said: “We know that up to 70% of the success of an electronic patient record deployment rests on achieving rapid and widespread user adoption1. uPerform can help organisations to secure that adoption by reinforcing training and providing support and tips while users work.”

“Once systems are in place, uPerform can also reduce the burden of onboarding and supporting new and temporary users. It gives them access to protocols and knowledge while they do what they want to do; which is spend time with patients.”

“Deploying a major healthcare IT system is a major undertaking, and one that uPerform can support by delivering training and knowledge to users, as they need it.”



To participate in HTN 100 email

Sponsored by CCube Solutions

CCube Solutions specialises in providing Electronic Document and Content Management & Workflow solutions, based on the CCube software suite. Systems scale from small departmental applications to large enterprise -wide solutions and include: the CCube Portal, Electronic Forms, Workflow, Content Searching, and CCube Electronic Document & Records Management System (EDRMS).